Drug Information

Drug General Information
Drug ID
D07TYE
Former ID
DIB015556
Drug Name
GS-9857
Indication HCV infection [ICD9: 070.4, 070.5, 070.70; ICD10:B17.1, B18.2] Phase 2 [524851]
Target and Pathway
Target(s) Nonstructural protein NS3 Target Info Inhibitor [550822]
References
Ref 524851ClinicalTrials.gov (NCT02202980) Efficacy and Safety of Oral Regimens for the Treatment of Chronic HCV Infection. U.S. National Institutes of Health.
Ref 550822Clinical pipeline report, company report or official report of Gilead.

If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.